
Sign up to save your podcasts
Or


FTX Testimony and Moderna's New Drug (Podcast)Mike McGlone, Senior Commodity Strategist with Bloomberg Intelligence, and Nathan Dean, Senior Policy Analyst, US and Latin America with Bloomberg Intelligence, and Katie Greifeld, cross asset reporter with Bloomberg News, join the show to discuss outlook for crypto coins and crypto policy in DC ahead of the testimony of FTX's new CEO. Moderna CEO Stephane Bancel discusses the company's skin cancer drug breakthrough. Annie Massa, cross asset reporter with Bloomberg News, and Barry Ritholtz, host of Bloomberg's "Masters in Business," join to discuss the FTX testimony on Capitol Hill. Hosted by Paul Sweeney and Matt Miller.
See omnystudio.com/listener for privacy information.
By Bloomberg3.8
381381 ratings
FTX Testimony and Moderna's New Drug (Podcast)Mike McGlone, Senior Commodity Strategist with Bloomberg Intelligence, and Nathan Dean, Senior Policy Analyst, US and Latin America with Bloomberg Intelligence, and Katie Greifeld, cross asset reporter with Bloomberg News, join the show to discuss outlook for crypto coins and crypto policy in DC ahead of the testimony of FTX's new CEO. Moderna CEO Stephane Bancel discusses the company's skin cancer drug breakthrough. Annie Massa, cross asset reporter with Bloomberg News, and Barry Ritholtz, host of Bloomberg's "Masters in Business," join to discuss the FTX testimony on Capitol Hill. Hosted by Paul Sweeney and Matt Miller.
See omnystudio.com/listener for privacy information.

977 Listeners

1,173 Listeners

2,175 Listeners

427 Listeners

970 Listeners

196 Listeners

1,044 Listeners

191 Listeners

71 Listeners

1,320 Listeners

65 Listeners

80 Listeners

30 Listeners

64 Listeners

4 Listeners

58 Listeners

233 Listeners

230 Listeners

69 Listeners

87 Listeners

80 Listeners

81 Listeners

85 Listeners

403 Listeners

19 Listeners

14 Listeners

7 Listeners

2 Listeners

119 Listeners

24 Listeners